Fresh Rounds

Neuropathix, Inc. funding

Neuropathix, Inc., a biotechnology company based in Doylestown, PA, filed a Form D with the SEC on November 17, 2025 and reported a $50M offering with no sales yet.

Amount raisedNot yet sold
Offering size$50M
Filed with the SECNovember 17, 2025
First saleYet to occur
IndustryBiotechnology
SecuritiesEquity
LocationDoylestown, PA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far0
Minimum investment$100K
Revenue range$1 - $1,000,000

Other health care rounds in Pennsylvania